SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (5109)12/11/2001 6:10:15 PM
From: IRWIN JAMES FRANKEL  Respond to of 52153
 
Hi Peter,

Given the difficulty of making short term calls on direction, I do not view the "long-term upward bias" as a small hurdle for shorting. In fact, I think it is a significant argument against sustainable profitability of the practice.

Just to "prove" Bulba's thesis, that shorts are not too smart - I am short BKS, DDS and JCP.

Peter please note, that these companies have NO PIPELINE, WILL NOT GET FDA APPROVAL, CAN'T ENROLL PATIENTS and sell TOXIC PRODUCTS. :-)

IJ



To: Biomaven who wrote (5109)12/11/2001 6:14:18 PM
From: BulbaMan  Read Replies (1) | Respond to of 52153
 
...a stock in a given period has about as much chance of going down say 50% as of going up the same 50%.
Peter: With all due respect, my guess is the total number of five-baggers and ten-baggers from your longs has easily exceeded the total number of 50% (or greater) gains on your shorts.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News